EXACT Sciences Corp (NASDAQ:EXAS)

CAPS Rating: 2 out of 5

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

Recs

0
Player Avatar Biotech2010 (87.49) Submitted: 1/26/2010 8:56:24 PM : Outperform Start Price: $3.47 EXAS Score: +174.10

3.39

Report this Post Reply

Featured Broker Partners


Advertisement